MMP2 and neoplasm: In vitro and in vivo studies in HepG2 cells and HepG2 tumour-bearing mice confirmed that overexpressed MMP2 protease in tumour tissue, together with intracellular glutathione, causes rapid release of doxorubicin, leading to inhibition of tumour growth [156].